Navigation Links
Kids With Psoriasis Get Inconsistent Care
Date:9/21/2011

WEDNESDAY, Sept. 21 (HealthDay News) -- How children are treated for psoriasis may depend on whether they see a pediatrician, dermatologist or internist, a new study suggests.

About 1 percent of children from birth to age 18 are affected by psoriasis, a skin condition that can lead to patches of itchy, flaky, dry skin.

Researchers from University of California, San Francisco School of Medicine and colleagues examined records from physicians on their pediatric psoriasis patients who scheduled visits over the course of nearly three decades.

Of 3.8 million visits, about 63 percent of kids saw a dermatologist; 17 percent saw a pediatrician; and 14 percent went to an internist.

Researchers found that pediatricians, dermatologists and internists often take different approaches to how they treat children with psoriasis, including what types of medication they use and how strong it is.

"Management of psoriasis in children can be challenging," the study's authors wrote, "owing to a paucity of data and lack of standardized guidelines specific to the pediatric population."

Most of the children in the study were given topical corticosteroids, particularly betamethasone.

Dermatologists and internists were most likely to prescribe strong steroids. The potency was roughly the same regardless of a child's age. Pediatricians, on the other hand, most often prescribed the topical immunosuppressant tacrolimus.

Severe cases of psoriasis were sometimes treated with phototherapy and oral medication.

The same number of boys and girls were treated for the condition. The vast majority of them, 93 percent, were white. Nearly half of the patients ranged in age from 13 to 18; 35 percent were 8 to 12 years old; and 18 percent were younger than 7 years old.

The study is published online in the Archives of Dermatology.

The researchers expressed concern about the lack of uniformity in treatment for psoriasis among children, particularly that strong topical corticosteroids are so often prescribed for young children.

"In our experience, the highest potency topical corticosteroids are not commonly needed for psoriasis in young children," the researchers wrote. They concluded treatment guidelines should be established for pediatric psoriasis.

More information

The National Psoriasis Foundation has more on psoriasis in children.

-- Mary Elizabeth Dallas

SOURCE: JAMA/Archives, news release, September 19, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Injectable Psoriasis Drugs May Not Hike Heart Risks: Study
2. Scientists Close in on Origins of Psoriasis, Eczema
3. Some Drugs for Rheumatoid Arthritis, Psoriasis May Cut Diabetes Risk
4. Multitasking meds: Scientists discover how drug for leukemia, psoriasis, may tackle vascular disease
5. Study Sees Link Between Psoriasis, Obesity in Kids
6. Psoriasis, High Blood Pressure May Be Linked
7. Extremely obese children have higher prevalence of psoriasis, higher heart disease risk
8. Severe psoriasis linked to major adverse cardiovascular events
9. Psoriasis medication rises hope in the fight against multiple sclerosis
10. Psoriasis Linked to Raised Heart Risks
11. Kids With Psoriasis Often at Risk of Being Bullied: Survey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... Aliso Viejo, California (PRWEB) , ... December 04, ... ... self-animating lower third presets that have new attractive animation styles with unique displacement ... Pro3rd Displace features 30 pre-animated lower third designs. Choose from a variety of ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of ... Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, ... Jason brings extensive financial and operational leadership experience to Advanced Inc. He began his ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 /PRNewswire/ ... SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the ... by 45.3% compared to placebo (1.63 vs 2.98, p=0.010) ... Novartis today announced that the data are being featured ... American Society of Hematology (ASH) Annual Meeting and ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: